...
....
Pharmaceutical
Biotechnology

> See specialized channels
Medical Devices & Diagnostics
> See specialized channels
Industrial
Biotechnology
> See specialized channels


  Join us

  Follow us on Twitter   Join our LinkedIn Group   Our Blog

Biotech News App
Provides access to the latest biotech press releases ...more

Android_Logo App Store RIM_Logo_small

Media Partnership:
Want to have your RSS feed integrated on our website? Contact us
RSS Feeds RSS Feeds
JoomlaWatch Stats 1.2.9 by Matej Koval
For Editors
Sign up for press releases
For Companies
Sign up for our newsletter


All Biotech Press Releases



> Quantapore Inc. Closes Series C Financing Round
09/27/16
> Shuwen Biotech's Clinical Lab Receives Accreditation from College of American Pathologists
09/23/16
> Nuevolution: Oral Presentation of Preclinical and Preliminary Toxicology Data on its BET BD1 Program at Discovery on Target 2016
09/22/16
> Orchard Therapeutics Announces Presentations from UCL/GOSH and UCLA Academic Collaborators on Clinical Data in ADA-SCID Using Ex-Vivo Lentiviral Gene Therapy at September 2016 ESID and ESGCT Congresses
09/21/16
> FierceBiotech Names Orchard Therapeutics Limited as One of Its “Fierce 15” Biotech Companies of 2016
09/21/16
> RedHill Biopharma and IntelGenx Announce RIZAPORT® Commercialization Term Sheet with Pharmatronic Co. for Korea
09/21/16
> TVM Life Science Ventures VII Announces Investment in AurKa Pharma Inc.
09/19/16
> osteomiR™: Worldwide First miRNA-based Test for Early Detection of Osteoporosis
09/19/16
> Nuevolution: Presentation of Preclinical Data on its BET BD1 Program at Discovery on Target 2016
09/16/16
> Sartorius Stedim Biotech Presents Sartocon® Slice 50 ECO
09/15/16
> RedHill Biopharma Announces Research Collaboration with Stanford University for YELIVA™
09/12/16
> RedHill Biopharma Announces Phase Ib/II Study with YELIVA™ Initiated for Multiple Myeloma at a Leading U.S. Academic Medical Center
09/08/16
> OrthoSera Receives CE Mark for hypACT™ Device to Regenerate Osteoarthritic Bone
09/07/16
> BioMed X Announces the Start of New Research Team on Oral Biofilm Disruption through Continued Collaboration with Johnson & Johnson Innovation
09/06/16
> AGC Acquires a Leading German Biopharmaceutical CMO
09/06/16
> Celonic and IBI-Lorenzini Announce a Strategic Collaboration on CHOvolution™, an Innovative Integrated Cell Line Development Platform
09/05/16
> Sartorius Stedim Biotech Presents the First Fully Integrated Upstream Platform
09/01/16
> Adherium Expands Its International Presence Announces Mr Thomas Lynch as Chairman and Dr Doug Wilson as Medical Director
09/01/16
> RedHill Biopharma Announces Approval of a European Patent Supporting RHB-104 for Multiple Sclerosis
08/29/16
> New England Journal of Medicine Publishes MINDACT Trial Results Proving the Clinical Utility of MammaPrint® in Assisting Physicians to Identify Early-Stage Breast Cancer Patients who can Safely Forgo Chemotherapy
08/24/16
> AYOXXA and Märzhäuser Introduce a Benchtop Device for Protein Multiplex Analysis
08/22/16
> RedHill Biopharma Provides 2016 Semi-Annual R&D Update
08/11/16
> Selvita Signs a Significant Collaboration with the University of California, San Francisco (UCSF)
08/09/16
> The World’s First Smart Insulin Pens with Automatic Wireless Data Transfer (868 MHz or Bluetooth®)
08/04/16
> ITM's Subsidiary ITG Receives Drug Approval for EndolucinBeta®
08/04/16
> RedHill Biopharma Announces Last Patient Visit in Phase IIa Study with RHB-104 for Multiple Sclerosis
08/01/16
> Trod Medical Receives a New Patent Allowance for Prostate Focal Therapy Encage™ Device
08/01/16
> Epidarex Capital Creates Nodthera Limited
07/28/16
> ARTES and Burnet Institute Join Forces to Develop Novel Hepatitis C Vaccine
07/26/16
> FDA Grants QIDP and Fast Track Designations to MCB3837, Morphochem’s Novel Intravenous Antibacterial to Treat C. Difficile Infections
07/25/16
 
<< Start < Prev 1 2 3 4 5 6 7 8 9 10 Next > End >>
Page 1 of 43